Search

Boily-Larouche, G, Carson, G, Golding, J, Depoortere, E, Almeida, JR, Vaux, R, Paparella, G, Vitali, D, Khursigara, D, Madelaine, C, Lay, AM, Kerstiens, B, Yazdanpanah, Y, Kaushic, C, Zaidi, A, Saville, M, Yeskey, D, Gray, G, Veloso, V, Koopmans, Marion, Fisman, D, Crooks, K, Camargo, K, Co-chairs, Meeting, Group, COVID-19 Research GloPID-R Synergies Meeting Working, and Virology

Margo Warren, Birgitta Henriques-Normark, Ramanan Laxminarayan, Ghada Zoubiane, Gian Maria Rossolini, Till T. Bachmann, Adam P. Roberts, Alison Holmes, Sabiha Y. Essack, Benedikt Huttner, Steven J. Hoffman, Charu Kaushic, Herman Goossens, Norio Ohmagari, Srinivas Murthy, Evelina Tacconelli, Jesús Rodríguez-Baño, Shawon Lahiri, Laura Plant, Patriq Fagerstedt, Rafael Cantón, Cornelius J. Clancy, Constance Schultsz, [Rodríguez-Baño,J] Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain. [Rodríguez-Baño,J] Departamento de Medicina, Universidad de Sevilla, Seville, Spain. [Rodríguez-Baño,J] Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Rossolini,GM] Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. [Rossolini,GM] Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy. [Schultsz,C] Department of Global Health–AIGHD Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Tacconelli,E] Division of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy. [Murthy,S] BC Children’s Hospital, University of British Columbia, Vancouver, Canada. [Ohmagari,N] Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. [Holmes,A] Department of Medicine, Faculty of Medicine, Imperial College London, London, UK. [Bachmann,T] The University of Edinburgh, Edinburgh Medical School, Division of Infection and Pathway Medicine, The Chancellor’s Building, Edinburgh, UK. [Goossens,H] Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. [Canton,R] Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain. [Canton,R] Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Roberts,AP] Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK. [Henriques-Normark,B] Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. [Henriques-Normark,B] Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. [Clancy,CJ] University of Pittsburgh, Pittsburgh, PA, USA. [Huttner,B] Division of Infectious Diseases, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Geneva, Switzerland. [Fagerstedt,P, Lahiri,S] JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden. [Kaushic,C, Plant,L] Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada. [Kaushic,C] McMaster Immunology Research Center, Department Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. [Hoffman,SJ] Global Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health and Osgoode Hall Law School, York University, Toronto, Canada. [Warren,M] Access to Medicine Foundation, Amsterdam, The Netherlands. [Zoubiane,G, Essack,S] International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark. [Essack,S] Antimicrobial Research Unit, University of KwaZulu-Natal, Durban, South Africa. [Laxminarayan,R] Center for Disease Dynamics, Economics & Policy, New Delhi, India. [Rodríguez-Baño,J] Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III. Madrid, Spain., APR would like to acknowledge funding from the AMR CrossCouncil Initiative through a grant from the Medical Research Council, a Council of UK Research and Innovation [grant number MR/S004793/1], the National Institute for Health Research [grant number NIHR200632] and the Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via the Medical Research Council in the UK [grant number MR/S037640/1]. JRB and RC acknowledge funding on AMR from Plan Nacional de I+D+i 2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/0001 and RD16/0016/ 0011], co-financed by the European Regional Development Fund ‘A way to achieve Europe’, Operative Program Intelligence Growth 2014–2020. JRB also acknowledges the Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via Instituto de Salud Carlos III [grant number AC16/00076]. ET acknowledges funding on AMR from the Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via the German Federal Ministry of Education and Research (BMBF) [grant number 01KI1830], Innovative Medicines Initiative 1 and 2 Joint Undertaking [grants number 115737,115523 and820755] and the Global Antibiotic Research and Development Partnership (GARDP). LP, PF and SL would like to acknowledge funding to the JPIAMR from the European Commission (EXEDRA, JPI-EC-AMR and JPIAMR-ACTION)., Medical Research Council (UK), UK Research and Innovation, National Institute for Health Research (UK), Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades (España), Red Española de Investigación en Patología Infecciosa, European Commission, Federal Ministry of Education and Research (Germany), Innovative Medicines Initiative, Global Health, AII - Infectious diseases, and APH - Global Health